H.L. Ormond & Company’s Abbott ABT Stock Holding History

H.L. Ormond & Company’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,724	Closed	-$222K	–	104
2021 Q4	$222K	Buy	+1,724	New	+$221K	0.26%	99

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

H.L. Ormond & Company's ABT Position: Q1 2022 in Review

H.L. Ormond & Company sold out of Abbott (ABT) in Q1 2022, closing a stake of 1,724 shares — an estimated $222K sold.

H.L. Ormond & Company first reported a position in ABT in Q4 2021 and held it in 1 quarter. The position peaked at $222K in Q4 2021. 2,760 funds tracked by Wall St. Rank hold ABT as of Q1 2022.

H.L. Ormond & Company reported no remaining Abbott position as of Q1 2022 after selling out during the quarter.
H.L. Ormond & Company sold 1,724 Abbott shares in Q1 2022, an estimated $222K.
H.L. Ormond & Company first reported a position in Abbott in Q4 2021 and held it in 1 quarter.
H.L. Ormond & Company's Abbott position peaked at $222K in Q4 2021.
2,760 funds tracked by Wall St. Rank held Abbott as of Q1 2022.

Based on H.L. Ormond & Company's 13F filing for Q1 2022, filed 11 May 2022.